Trelegy Ellipta

Trelegy Ellipta® is a prescription inhaler used for long-term maintenance treatment of asthma (in adults) and COPD. It combines three types of medicines in one inhaler: an inhaled corticosteroid (ICS) to reduce inflammation, a long-acting muscarinic antagonist (LAMA), and a long-acting beta2-agonist (LABA) to help keep airways open. It’s designed for once-daily use to support stable breathing over time - not for sudden symptoms.

• Contains fluticasone (anti-inflammatory), umeclidinium (LAMA), and vilanterol (LABA)
• Used daily for asthma maintenance in adults (18+)
• Also prescribed for COPD maintenance
• Not a rescue inhaler for asthma attacks or sudden breathing problems
• Requires a prescription and provider evaluation

Trelegy Ellipta® is a dry powder inhaler (DPI) that you inhale through your mouth, usually once daily at the same time each day. It works best when used consistently, even if you feel well, because it helps maintain control rather than provide immediate relief.

• Inhaled through the Ellipta device (breath-activated)
• Taken once daily as prescribed
• Rinse your mouth after each dose to reduce irritation risk
• Do not use more often than prescribed
• Avoid combining with other LABA or similar inhalers unless directed

If you experience sudden breathing symptoms, use a rescue inhaler instead of taking an extra dose.

Trelegy Ellipta® can cause side effects, although not everyone experiences them. Some are related to the airways, while others may affect different parts of the body due to the combination of medications.

• Common: sore throat, cough, headache, upper respiratory infections
• Possible: oral thrush (fungal infection), hoarseness, sinus symptoms
• May increase risk of infections, including pneumonia (especially in COPD)
• Get medical help right away if breathing worsens after use
• Contact your provider if you notice chest pain, eye pain, or difficulty urinating

If symptoms feel unusual or persistent, discuss them with your provider. Refer to the Important Safety / Prescribing Information for full details.

Trelegy Ellipta® is a prescription medication, so a healthcare provider must review your condition before prescribing it.

• Complete an online consultation
• Provider evaluates your asthma or COPD history
• Prescription is issued if appropriate
• Medication is sent to a pharmacy or delivered

No - Trelegy Ellipta® is not a rescue inhaler and should not be used during an asthma attack. It works over time and will not provide fast relief.

• Use your rescue inhaler for immediate symptoms
• Keep emergency medication accessible at all times
• Delaying proper treatment can worsen breathing problems

If your symptoms don’t improve after using a rescue inhaler, seek medical help right away.

Yes - Trelegy Ellipta® is used for daily control, but you still need a rescue inhaler for sudden symptoms.

• Trelegy helps maintain long-term control
• Rescue inhalers act quickly during flare-ups
• Both may be part of your treatment plan

If you’re using your rescue inhaler more often than usual, contact a provider.

If you miss a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed one.

• Do not take two doses at once
• Continue your regular schedule
• Use reminders to stay consistent

Daily use helps maintain control.

No - you should not take extra doses unless your provider instructs you to. Taking more will not provide immediate relief.

• Trelegy is not fast-acting
• Overuse may increase side effects
• Use your rescue inhaler for sudden symptoms

Rinsing your mouth after each dose helps reduce the risk of oral thrush, a fungal infection that can occur with inhaled corticosteroids.

• Rinse with water and spit it out
• Do not swallow the rinse water
• Helps protect your mouth and throat

It depends on the type of inhaler. Some combinations are safe, while others may increase risks.

• Avoid using multiple LABA inhalers together
• Avoid combining with similar anticholinergic medications
• Always check with your provider

Your provider will help determine the safest treatment plan.

Yes - you can eat or drink normally after using Trelegy Ellipta®.

• Rinse your mouth before eating or drinking
• No specific food restrictions are listed
• Maintain normal eating habits

If you have concerns, your provider can offer guidance.

There are no specific restrictions listed, but moderation is recommended.

• Moderate alcohol intake is generally acceptable
• Avoid excessive drinking
• Monitor how your body responds

Most people can continue normal activities like driving, but it depends on how you feel.

• Watch for dizziness or palpitations
• Avoid driving if you feel unwell
• Give your body time to adjust

Use caution if you have glaucoma or urinary retention issues, as symptoms may worsen.

• Inform your provider before starting
• Watch for eye pain or vision changes
• Monitor for difficulty urinating

Contact your provider if symptoms occur.

Trelegy Ellipta® may not be suitable if you have a severe milk protein allergy.

• Contains lactose, which may include milk proteins
• Inform your provider about allergies
• Ask about alternative options

Always confirm before starting treatment.

Store your inhaler in a dry place at room temperature.

• Keep away from heat and moisture
• Store in original packaging until use
• Avoid extreme temperatures

Proper storage helps maintain effectiveness.

Yes - Trelegy Ellipta® is a prescription medication.

• Requires a provider evaluation
• Not everyone will qualify
• Prescribed based on medical need

US Quick Health can simplify access, but approval is always required.

Trelegy Ellipta® (Fluticasone Furoate/Umeclidinium/Vilanterol 100/62.5/25 mcg, 200/62.5/25 mcg) - triple therapy inhaler (ICS + LAMA + LABA) dry powder inhaler (DPI) used for once-daily maintenance treatment of asthma and COPD; not for acute bronchospasm. / Source: NCBI

Link: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b5a81d5a-4648-4c7a-951d-33c014a63c7e / Published: Not clearly shown on DailyMed